alprazolam and gsk 561679

alprazolam has been researched along with gsk 561679 in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Davis, A; Ernst, M; Grillon, C; Hale, E; Lieberman, L; Pine, DS1

Trials

1 trial(s) available for alprazolam and gsk 561679

ArticleYear
The CRH1 antagonist GSK561679 increases human fear but not anxiety as assessed by startle.
    Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2015, Mar-13, Volume: 40, Issue:5

    Topics: Acoustic Stimulation; Adult; Alprazolam; Anti-Anxiety Agents; Anticipation, Psychological; Anxiety; Azabicyclo Compounds; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Electroshock; Fear; Female; Humans; Neuropsychological Tests; Oxadiazoles; Psychotropic Drugs; Receptors, Corticotropin-Releasing Hormone; Reflex, Startle; Surveys and Questionnaires; Uncertainty

2015